Helping migrant men in Johannesburg use HIV prevention methods
Development and Pilot RCT of a "Healthy Welcome" Intervention to Increase PrEP Uptake and Adherence Among Migrant Men in Johannesburg
['FUNDING_OTHER'] · BRIGHAM AND WOMEN'S HOSPITAL · NIH-10923600
This study is testing a friendly program called 'Healthy Welcome' to help migrant men in Johannesburg learn about and consistently use PrEP for HIV prevention, making it easier for them to access the medication and feel comfortable at healthcare facilities.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BRIGHAM AND WOMEN'S HOSPITAL (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10923600 on ClinicalTrials.gov |
What this research studies
This research aims to develop and test a program called the 'Healthy Welcome' intervention to help migrant men in Johannesburg start and stick to using pre-exposure prophylaxis (PrEP) for HIV prevention. The program will address common barriers these men face, such as lack of knowledge about PrEP, stigma at healthcare facilities, and unfamiliarity with local health services. By connecting them with community pharmacies, the intervention seeks to improve access to and adherence to PrEP. The research will involve pilot testing this approach to evaluate its effectiveness in increasing PrEP uptake among this high-risk population.
Who could benefit from this research
Good fit: Ideal candidates for this research are migrant men living in Johannesburg who are at risk of HIV and are interested in using PrEP.
Not a fit: Patients who are not at risk of HIV or who are not migrants may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of HIV among migrant men by improving their access to and adherence to preventive treatments.
How similar studies have performed: Previous research has shown that targeted interventions can effectively increase PrEP uptake among high-risk populations, suggesting that this approach may also be successful.
Where this research is happening
BOSTON, UNITED STATES
- BRIGHAM AND WOMEN'S HOSPITAL — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NARDELL, MARIA FRANCESCA — BRIGHAM AND WOMEN'S HOSPITAL
- Study coordinator: NARDELL, MARIA FRANCESCA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus